0000939767-18-000031.txt : 20180302
0000939767-18-000031.hdr.sgml : 20180302
20180302200003
ACCESSION NUMBER: 0000939767-18-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haley Patrick J.
CENTRAL INDEX KEY: 0001692954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 18664142
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_152003878922288.xml
FORM 4
X0306
4
2018-02-28
0
0000939767
EXELIXIS, INC.
EXEL
0001692954
Haley Patrick J.
210 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. Vice President, Commercial
Common Stock
2018-02-28
4
M
0
10625
1.76
A
155519
D
Common Stock
2018-02-28
4
M
0
3000
5.50
A
158519
D
Common Stock
2018-02-28
4
S
0
45029
27.13
D
113490
D
Common Stock
23539
I
By spouse
Common Stock
10101
I
By 401(k)
Option (right to buy)
1.76
2018-02-28
4
M
0
10625
0
D
2015-11-17
2021-11-16
Common Stock
10625.0
39375
D
Option (right to buy)
5.5
2018-02-28
4
M
0
3000
0
D
2012-09-28
2018-09-27
Common Stock
3000.0
0
D
Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.03 to $27.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 28, 2018.
The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, was exercisable as to 40,625 shares as of the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of November 17, 2014 grant date.
The option, representing the right to purchase a total of 3,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2018-03-02